Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZBTB9 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | FGF17 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | DUSP7 | gCSI | pan-cancer | AAC | 0.16 | 0.009 |
mRNA | IRX5 | gCSI | pan-cancer | AAC | -0.17 | 0.009 |
mRNA | ERVFRD-1 | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
mRNA | SYNGAP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | NUFIP2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | IKBKAP | gCSI | pan-cancer | AAC | 0.16 | 0.009 |
mRNA | MORN3 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
mRNA | COMMD2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |